Wells Fargo & Company Cumberland Pharmaceuticals Inc Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 65 shares of CPIX stock, worth $95. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 63
3.17%
Holding current value
$95
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CPIX
# of Institutions
25Shares Held
2.09MCall Options Held
38.1KPut Options Held
200-
Jim Simons Renaissance Technologies LLC | New York, Ny543KShares$797,7140.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$550,1480.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX358KShares$525,6940.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX287KShares$421,3820.01% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$276,6010.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $21.6M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...